Pfizer's Total Interest In Haleon To Reduce From Approx. 22.6% To Approx. 15.0%
I'm PortAI, I can summarize articles.
Pfizer is reducing its stake in Haleon from approximately 22.6% to 15.0% by selling 640 million shares at 380 pence each, raising about £2.43 billion. Additionally, Haleon will buy back around 60.5 million shares from Pfizer for £230 million. The total proceeds from both transactions will be approximately £2.66 billion, with settlement expected on 3 October 2024. Haleon's CEO stated this buyback aligns with their commitment to return £500 million to shareholders this year.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments